Summit Therapeutics
SMMT
SMMT
97 hedge funds and large institutions have $86.3M invested in Summit Therapeutics in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 93 → 97 (+4)
0.09% more ownership
Funds ownership: 4.63% → 4.72% (+0.09%)
Holders
97
Holding in Top 10
–
Calls
$896K
Puts
$101K
Top Buyers
| 1 | +$2.4M | |
| 2 | +$2.23M | |
| 3 | +$2.04M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$495K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$459K |
Top Sellers
| 1 | -$5.87M | |
| 2 | -$581K | |
| 3 | -$363K | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
-$131K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$75.2K |